| Gene symbol | CCR4 | Synonyms | CC-CKR-4, CD194, CKR4, CMKBR4, ChemR13, HGCN:14099, K5-5 | Type of gene | protein-coding |
| Chromosome | 3 | Map location | 3p22.3 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | PertOrg | ||||
| Description | C-C motif chemokine receptor 4 | ||||
| Gene symbol | TNFRSF8 | Synonyms | CD30, D1S166E, Ki-1 | Type of gene | protein-coding |
| Chromosome | 1 | Map location | 1p36.22 | dbXrefs | |
| Description | TNF receptor superfamily member 8 | ||||
| GTO ID | GTC3626 |
| Trial ID | NCT06090864 |
| Disease | Hodgkin's Lymphoma |
| Altered gene | CD30|CCR4 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | ATLCAR.CD30.CCR4 cells |
| Phase | Phase1|Phase2 |
| Recruitment status | Recruiting |
| Title | The Administration of T Lymphocytes Expressing the CD30 Chimeric Antigen Receptor (CAR) and CCR4 for Relapsed/Refractory CD30+ Hodgkin s Lymphoma |
| Year | 2024 |
| Country | United States |
| Company sponsor | UNC Lineberger Comprehensive Cancer Center |
| Other ID(s) | LCCC2222-ATL |
| Cohort 1 | |||||||||
|
|||||||||